首页> 美国卫生研究院文献>European Journal of Human Genetics >The mutation spectrum in RECQL4 diseases
【2h】

The mutation spectrum in RECQL4 diseases

机译:RECQL4疾病的突变谱

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mutations in the RECQL4 gene can lead to three clinical phenotypes with overlapping features. All these syndromes, Rothmund–Thomson (RTS), RAPADILINO and Baller–Gerold (BGS), are characterized by growth retardation and radial defects, but RAPADILINO syndrome lacks the main dermal manifestation, poikiloderma that is a hallmark feature in both RTS and BGS. It has been previously shown that RTS patients with RECQL4 mutations are at increased risk of osteosarcoma, but the precise incidence of cancer in RAPADILINO and BGS has not been determined. Here, we report that RAPADILINO patients identified as carriers of the c.1390+2delT mutation (p.Ala420_Ala463del) are at increased risk to develop lymphoma or osteosarcoma (6 out of 15 patients). We also summarize all the published RECQL4 mutations and their associated cancer cases and provide an update of 14 novel RECQL4 mutations with accompanying clinical data.
机译:RECQL4基因的突变可导致三种具有重叠特征的临床表型。 Rothmund-Thomson(RTS),RAPADILINO和Baller-Gerold(BGS)等所有这些综合征均以生长迟缓和放射状缺陷为特征,但RAPADILINO综合征缺乏主要的皮肤表现,即薄木皮病,这是RTS和BGS的标志性特征。先前已显示具有RECQL4突变的RTS患者患骨肉瘤的风险增加,但尚未确定RAPADILINO和BGS中癌症的确切发病率。在这里,我们报告说,被确定为c.1390 + 2delT突变携带者的RAPADILINO患者(p.Ala420_Ala463del)患淋巴瘤或骨肉瘤的风险增加(15名患者中有6名)。我们还总结了所有已发布的RECQL4突变及其相关的癌症病例,并提供了14种新颖RECQL4突变的更新以及相关的临床数据。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号